Telangana minister launches 5 projects at Genome Valley
Real Estate

Telangana minister launches 5 projects at Genome Valley

The five projects involve a cumulative investment of Rs 11 billion
Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs.

These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector.

Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so.

Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad.

See also:
Volcan Investments, not Vedanta, to invest in semi-conductor plant
MeitY Startup Hub, Meta collaborate to accelerate XR startups


The five projects involve a cumulative investment of Rs 11 billion Heralding a new phase of development at the life sciences cluster Genome Valley, Telangana Industries Minister K T Rama Rao his week laid the foundation stone for five projects involving a cumulative investment of Rs 11 billion and having the potential to create 3,000 jobs. These also include the Biopharma Hub (B-Hub), a PPP project of Telangana government, Telangana State Industrial Infrastructure Corporation (TSIIC), and the Department of Biotechnology. This aims at catalysing the biopharmaceuticals sector. Rama Rao said the demand for space at Genome Valley was on the rise. “We have a good problem on hand. We are running out of space at the cluster,” he said, adding that various developments and expansions happening would add about 2 million sq ft space in the next two years or so. Over 200 biotechnology, life sciences and pharmaceutical companies operate from Genome Valley, India’s first organised research and development cluster. It has more plug-and-play facilities than all other clusters put together. Various companies including Biological E Ltd and Indian Immunologicals have announced investments worth Rs 25 billion to increase vaccine manufacturing capacities. Homegrown pharmaceutical company Hetero will spend Rs 7.50 billion to set up sterile pharmaceutical products while global giant Roche is setting up its analytics and technology centre in Hyderabad. See also: Volcan Investments, not Vedanta, to invest in semi-conductor plantMeitY Startup Hub, Meta collaborate to accelerate XR startups

Next Story
Technology

We’re building robots that flow, not just move

Founded in 2021, Flo Mobility is reimagining construction automation with vision-AI robots designed for seamless movement through complex sites. In conversation with CW, Manesh Jain, Founder & CEO, discusses the company’s origin, its LiDAR-free tech stack, and expansion plans in the Middle East and US.What inspired the name Flo Mobility? Why ‘Flo’ and not ‘Flow’?When we started the company in 2021, our focus was on building autonomous navigation systems for robots. Since our work centred around robot movement, ‘mobility’ naturally became part of the name. We wanted to co..

Next Story
Real Estate

We’re committed to setting benchmarks in sustainable luxury living

From a landmark land acquisition in Boisar to ambitious launches across the Mumbai Metropolitan Region (MMR), National Capital Region (NCR), Bengaluru and Pune, Birla Estates is driving future-ready growth with a strong focus on sustainability, partnerships and premium living, firmly anchored in its LifeDesigned® philosophy. K T Jithendran, Managing Director & CEO, outlines the company’s premium, sustainable growth playbook in conversation with PRATAP PADODE, Editor-in-Chief, CW. Excerpts:Birla Estates recently acquired a 70.92-acre land parcel in Boisar, Maharashtra, for..

Next Story
Infrastructure Urban

Mumbai’s land crunch and ageing homes call for structured renewal

Founded in 2022, Etonhurst Capital Partners is a real-estate fund management platform focused on the Indian market. As the firm achieves the first close of Rs 1.8 billion for its debut Rs 5 billion fund, Bamasish Paul, Co-founder, Managing Partner & CEO, discusses its sharp focus on redevelopment-driven value creation in Mumbai’s urban core with CW. Excerpts:Etonhurst Capital has achieved a significant milestone with the first close of Rs 1.8 billion for its Rs 5 billion fund. What factors contributed to this early success and how do you plan to attract further investments to r..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?